XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT

Realtime	Geld	Brief	Zeit
	8,400	8,850	22:15

Realtime

Geld

Brief

Zeit

8,400

8,850

22:15

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 18.12.2023

The following instruments on Boerse Frankfurt do have their last trading day on 18.12.2023
Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 18.12.2023

ISIN Name
AU000000JHG6 JANUS HENDERSON GRP CDIS
BE0974461940 MDXHEALTH S.A.
CA10170T3073 BOUNDARY GOLD A.COPP.MIN.
GB00BNG8T458 SMOOVE PLC LS -,004
IT0005523797 LIFESTYLE GROUP S.P.A.
NO0003103103 Q-FREE ASA NK -,38
US16955F1075 CHINDATA GRP.HLDS A DL
US87241J1043 TFF PHARMAC.INC. DL-,001
XS2070055095 SCHOELLER P. 19/24 REGS

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden

In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.

Hier klicken

Zeit	Aktuelle Nachrichten
07.02.	Boundary Gold and Copper Mining Ltd (3): Boundary Gold appoints Torres as director
18.12.23	XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 18.12.2023	The following instruments on Boerse Frankfurt do have their last trading day on 18.12.2023Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 18.12.2023ISIN NameAU000000JHG6 JANUS... ► Artikel lesen
08.12.23	Boundary Gold and Copper Mining Ltd. shifts to NEX with new ticker BDGC.H
07.12.23	Boundary Gold and Copper Mining Ltd (3): Boundary Gold to resume trading Dec. 11
06.12.23	Boundary Gold and Copper Mining Ltd (3): Boundary shareholders OK Kena-Daylight property sale

Zeit

Aktuelle Nachrichten

07.02.

Boundary Gold and Copper Mining Ltd (3): Boundary Gold appoints Torres as director

18.12.23

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 18.12.2023

08.12.23

Boundary Gold and Copper Mining Ltd. shifts to NEX with new ticker BDGC.H

07.12.23

Boundary Gold and Copper Mining Ltd (3): Boundary Gold to resume trading Dec. 11

06.12.23

Boundary Gold and Copper Mining Ltd (3): Boundary shareholders OK Kena-Daylight property sale

Zeit	Aktuelle Nachrichten
28.03.	Bain seeks backers for Chinese data center operator ChinData - report
28.03.	Bain Eyes New Backers for Multibillion-Dollar China Data-Center Firm Chindata
28.12.23	Chindata Group Holdings Ltd - 15-12G, Securities registration termination
19.12.23	Chindata Group Holdings Limited: Chindata Group Announces Completion of Going Private Transaction	BEIJING, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Chindata Group Holdings Limited ("Chindata Group" or the "Company") (Nasdaq: CD), a leading carrier-neutral hyperscale data center solution provider in Asia-Pacific... ► Artikel lesen
18.12.23	NSE - Chindata Group Holdings Ltd - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities

Zeit

Aktuelle Nachrichten

28.03.

Bain seeks backers for Chinese data center operator ChinData - report

28.03.

Bain Eyes New Backers for Multibillion-Dollar China Data-Center Firm Chindata

28.12.23

Chindata Group Holdings Ltd - 15-12G, Securities registration termination

19.12.23

Chindata Group Holdings Limited: Chindata Group Announces Completion of Going Private Transaction

BEIJING, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Chindata Group Holdings Limited ("Chindata Group" or the "Company") (Nasdaq: CD), a leading carrier-neutral hyperscale data center solution provider in Asia-Pacific...
► Artikel lesen

18.12.23

NSE - Chindata Group Holdings Ltd - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities

Zeit	Aktuelle Nachrichten
18.12.23	XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 18.12.2023		The following instruments on Boerse Frankfurt do have their last trading day on 18.12.2023Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 18.12.2023ISIN NameAU000000JHG6 JANUS... ► Artikel lesen

Zeit

Aktuelle Nachrichten

18.12.23

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 18.12.2023

Zeit	Aktuelle Nachrichten
Mi	MDxHealth SA GAAP EPS of -$0.31, revenue of $19.8M
Mi	MDxHealth SA - 6-K, Report of foreign issuer
Mi	MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed	MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed Year-over-year Q1 revenues increase by 35% to $19.8 millionIncreasing 2024 revenue guidance to $83-85 million, previously... ► Artikel lesen
12.03.	MDxHealth expands prostate cancer test portfolio
12.03.	MDxHealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering	Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering IRVINE, CA, and HERSTAL, BELGIUM - March 12, 2024 (GlobeNewswire) - MDxHealth SA (NASDAQ: MDXH) (the "Company" or... ► Artikel lesen

Zeit

Aktuelle Nachrichten

MDxHealth SA GAAP EPS of -$0.31, revenue of $19.8M

MDxHealth SA - 6-K, Report of foreign issuer

MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed

MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed Year-over-year Q1 revenues increase by 35% to $19.8 millionIncreasing 2024 revenue guidance to $83-85 million, previously...
► Artikel lesen

12.03.

MDxHealth expands prostate cancer test portfolio

12.03.

MDxHealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering

Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering IRVINE, CA, and HERSTAL, BELGIUM - March 12, 2024 (GlobeNewswire) - MDxHealth SA (NASDAQ: MDXH) (the "Company" or...
► Artikel lesen

Zeit	Aktuelle Nachrichten
18.12.23	XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 18.12.2023	The following instruments on Boerse Frankfurt do have their last trading day on 18.12.2023Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 18.12.2023ISIN NameAU000000JHG6 JANUS... ► Artikel lesen
14.12.23	Nasdaq Stockholm AB: Delisting of Q-Free ASA from Nasdaq First North Sweden NOK Segment (669/23)	Q-Free ASA has applied for its shares to be delisted from Nasdaq First North Sweden NOK segment. Nasdaq Stockholm AB has approved the application and decided to delist the shares in Q-Free ASA.... ► Artikel lesen
13.12.23	Q-Free ASA - Delisting
12.12.23	Q-Free ASA: Received application for delisting
11.12.23	Q-Free ASA: Q-Free: Minutes of Extraordinary General Meetings on 11 December 2023

Zeit

Aktuelle Nachrichten

18.12.23

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 18.12.2023

14.12.23

Nasdaq Stockholm AB: Delisting of Q-Free ASA from Nasdaq First North Sweden NOK Segment (669/23)

Q-Free ASA has applied for its shares to be delisted from Nasdaq First North Sweden NOK segment. Nasdaq Stockholm AB has approved the application and decided to delist the shares in Q-Free ASA....
► Artikel lesen

13.12.23

Q-Free ASA - Delisting

12.12.23

Q-Free ASA: Received application for delisting

11.12.23

Q-Free ASA: Q-Free: Minutes of Extraordinary General Meetings on 11 December 2023

Zeit	Aktuelle Nachrichten
Mi	TFF Pharmaceuticals, Inc.: TFF Pharmaceuticals Announces Closing of Pricing of $4.8 Million Public Offering
Di	TFF Pharmaceuticals announces pricing of $4.8M public offering
Di	TFF Pharmaceuticals, Inc.: TFF Pharmaceuticals Announces Pricing of $4.8 Million Public Offering
Mo	TFF Pharmaceuticals, Inc.: TFF Pharmaceuticals Makes Available Phase 2 Data from Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection Presented at the Recent ISHLT Annual Meeting	Data Now Available on Company Website Following 8-K Filing Data Demonstrate that Treatment with TFF TAC Prevents Lung Transplant Rejection at Only One-sixth of the Dose of Oral Tacrolimus and at Two-thirds... ► Artikel lesen
Mo	TFF Pharmaceuticals, Inc. - 8-K, Current Report

Zeit

Aktuelle Nachrichten

TFF Pharmaceuticals, Inc.: TFF Pharmaceuticals Announces Closing of Pricing of $4.8 Million Public Offering

TFF Pharmaceuticals announces pricing of $4.8M public offering

TFF Pharmaceuticals, Inc.: TFF Pharmaceuticals Announces Pricing of $4.8 Million Public Offering

TFF Pharmaceuticals, Inc.: TFF Pharmaceuticals Makes Available Phase 2 Data from Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection Presented at the Recent ISHLT Annual Meeting

Data Now Available on Company Website Following 8-K Filing Data Demonstrate that Treatment with TFF TAC Prevents Lung Transplant Rejection at Only One-sixth of the Dose of Oral Tacrolimus and at Two-thirds...
► Artikel lesen

TFF Pharmaceuticals, Inc. - 8-K, Current Report

Unternehmen / Aktien	Kurs	%
BOUNDARY GOLD AND COPPER MINING LTD	0,280	0,00 %
CHINDATA GROUP HOLDINGS LTD ADR	7,300	0,00 %
LIFESTYLE GROUP SPA	0,034	0,00 %
MDXHEALTH SA	2,995	0,00 %
Q-FREE ASA	0,992	0,00 %
TFF PHARMACEUTICALS INC	2,680	-0,74 %

Unternehmen / Aktien

Kurs

BOUNDARY GOLD AND COPPER MINING LTD

0,280

0,00 %

CHINDATA GROUP HOLDINGS LTD ADR

7,300

0,00 %

LIFESTYLE GROUP SPA

0,034

0,00 %

MDXHEALTH SA